✦ LIBER ✦

Sub-lethal radiation enhances anti-tumor immunotherapy in a transgenic mouse model of pancreatic cancer

✍ Scribed by Alexander Zhu Cao; Dylan Daniel; Douglas Hanahan

Book ID: 115010470
Publisher: BioMed Central
Year: 2002
Tongue: English
Weight: 384 KB
Volume: 2
Category: Article
ISSN: 1471-2407
DOI: 10.1186/1471-2407-2-11

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tumor-derived tissue factor activates co

Tumor-derived tissue factor activates coagulation and enhances thrombosis in a mouse xenograft model of human pancreatic cancer

✍ Wang, J.-G.; Geddings, J. E.; Aleman, M. M.; Cardenas, J. C.; Chantrathammachart 📂 Article 📅 2012 🏛 American Society of Hematology 🌐 English ⚖ 566 KB

Antitumor effects of L-BLP25 Antigen-Spe

Antitumor effects of L-BLP25 Antigen-Specific tumor immunotherapy in a novel human MUC1 transgenic lung cancer mouse model

✍ Gregory T Wurz, Audrey M Gutierrez… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 518 KB

CXCR4 peptide antagonist inhibits primar

CXCR4 peptide antagonist inhibits primary breast tumor growth, metastasis and enhances the efficacy of anti-VEGF treatment or docetaxel in a transgenic mouse model

✍ Saima Hassan; Marguerite Buchanan; Kaushar Jahan; Adriana Aguilar-Mahecha; Louis 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 527 KB

## Abstract CXCR4 is a chemokine receptor implicated in the homing of cancer cells to target metastatic organs, which overexpress its ligand, stromal cell‐derived factor (SDF)‐1. To determine the efficacy of targeting CXCR4 on primary tumor growth and metastasis, we used a peptide inhibitor of CXCR